论文部分内容阅读
目的比较胰岛素泵持续皮下输注胰岛素(continuous subcutaneous insulin infusion,CSI)及多次皮下注射胰岛素(multiple subcutaneous insulin injection,MSI)对控制围手术期糖尿病患者血糖水平、安全性等疗效观察.方法2010年9月至2012年9月,我院102例糖尿病围手术期患者,随机分组,分别应用胰岛素泵和常规皮下注射胰岛素控制血糖,观察血糖水平、胰岛素用量、低血糖发生率、切口愈合等级等指标,比较两组之间的差别.结果 CSII 组(A 组)达到理想血糖所需时间少于 MSI 组(B 组),所需胰岛素用量及低血糖发生率也低于 B 组.切口愈合等级两组无统计学意义.结论对择期手术患者胰岛素泵治疗能缩短术前待手术期,血糖达标时间减少,使患者血糖得到理想控制,减少低血糖发生,是控制围手术期血糖的有效办法.“,”Objective To assess the clinical therapeutic effect of the CSI(continuous subcutaneous insulin infusion) and the MSI(multiple subcutaneous insulin injection) to the perioperative diabetic patients. Methods From Sept. 2010 to Sept. 2012, 102 perioperative diabetic patients were randomly divided into the CSI group and the MSI group. After the treatment, the total clinical effect, such as the plasma glucose level, the dosage of insulin, the rate of hypoglycemia, the grades of the incision healing, were observed and analyzed to evaluate the differences between the two groups. Results The time of plasma glucose for achieving the target, the dosage of insulin, and rate of hypoglycemia were shorter in the CSI group (group A) than the MSI group (group B). There were no significance differences in the grades of incision healing between the two groups. Conclusion The application of CSI in the perioperative diabetic patients can bring better glucose control, shorten the time of plasma glucose for achieving the target and the preoperative preparation time. And it also can decrease the rate of hypoglycemia. Thus the CSI is an effective way to control the plasma glucose level of the perioperative diabetic patients.